Organic Letters
Letter
Sekiguchi, H.; Kobayashi, N.; Mori, A.; Funahashi, M.; Tamaoki, N. J.
Am. Chem. Soc. 2006, 128, 10930−10933.
materials remained inactive. These findings clearly underline
the importance of the developed method, allowing the efficient
and selective synthesis of bioactive complex dimeric hetero-
arenes.
(8) Li, N.-N.; Zhang, Y.-L.; Mao, S.; Gao, Y.-R.; Guo, D.-D.; Wang,
Y.-Q. Org. Lett. 2014, 16, 2732−2735.
(9) (a) Dohi, T.; Morimoto, K.; Kiyono, Y.; Maruyama, A.; Tohma,
H.; Kita, Y. Chem. Commun. 2005, 2930−2932. (b) Dohi, T.;
Morimoto, K.; Maruyama, A.; Kita, Y. Org. Lett. 2006, 8, 2007−2010.
(c) Kita, Y.; Morimoto, K.; Ito, M.; Ogawa, C.; Goto, A.; Dohi, T. J.
Am. Chem. Soc. 2009, 131, 1668−1669.
In conclusion, we have developed a regioselective nitro-
sonium ion-catalyzed dehydrogenative coupling of arylated
heteroarenes under mild conditions. The desired products were
formed smoothly with a fast reaction rate using molecular
oxygen as the stoichiometric oxidant, while water is formed as a
single byproduct. A comprehensive scope covering different
heterocycles was demonstrated, revealing a good functional
group tolerance. We demonstrated that dehydrogenative
coupling of heteroarenes allows the straightforward synthesis
of dimeric privileged scaffolds, which translated into the rapid
discovery of novel Hh inhibitors.
(10) Morimoto, K.; Dohi, T.; Kita, Y. Synlett 2017, 28, 1680−1694.
(11) (a) Matheson, I. M.; Musgrave, O. C.; Webster, C. J. Chem.
Commun. 1965, 0, 278−279. (b) Zhai, L.; Shukla, R.; Wadumethrige,
S. H.; Rathore, R. J. Org. Chem. 2010, 75, 4748−4760. (c) Navale, T.
S.; Thakur, K.; Rathore, R. Org. Lett. 2011, 13, 1634−1637. (d) Cho,
H. Y.; Scott, L. T. Tetrahedron Lett. 2015, 56, 3458−3462.
(12) Grzybowski, M.; Skonieczny, K.; Butenschon, H.; Gryko, D. T.
̈
Angew. Chem., Int. Ed. 2013, 52, 9900−9930.
(13) (a) Radner, F. J. Org. Chem. 1988, 53, 702−704. (b) Kim, E. K.;
Kochi, J. K. J. Org. Chem. 1989, 54, 1692−1702. (c) Tanaka, M.;
Nakashima, H.; Fujiwara, M.; Ando, H.; Souma, Y. J. Org. Chem. 1996,
61, 788−792.
(14) (a) Bering, L.; Antonchick, A. P. Org. Lett. 2015, 17, 3134−
3137. (b) Bering, L.; Antonchick, A. P. Chem. Sci. 2017, 8, 452−457.
(c) Manna, S.; Antonchick, A. P. Chem. - Eur. J. 2017, 23, 7825−7829.
(15) (a) Shi, Z.; Zhang, C.; Tang, C.; Jiao, N. Chem. Soc. Rev. 2012,
41, 3381−3430. (b) Chen, K.; Zhang, P.; Wang, Y.; Li, H. Green Chem.
2014, 16, 2344−2374.
(16) (a) Su, B.; Li, L.; Hu, Y.; Liu, Y.; Wang, Q. Adv. Synth. Catal.
2012, 354, 383−387. (b) Ren, Y.-L.; Wang, W.; Zhao, B.; Tian, X.;
Zhao, S.; Wang, J.; Li, F. ChemCatChem 2016, 8, 3361−3366.
(17) Yoshimura, A.; Zhdankin, V. V. Chem. Rev. 2016, 116, 3328−
3435.
(18) (a) Lee, K. Y.; Kuchynka, D. J.; Kochi, J. K. Inorg. Chem. 1990,
29, 4196−4204. (b) Colomer, I.; Batchelor-McAuley, C.; Odell, B.;
Donohoe, T. J.; Compton, R. G. J. Am. Chem. Soc. 2016, 138, 8855−
8861.
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
■
S
General experimental procedures, detailed optimization
studies, details on control experiments, mechanistic
studies and biological methods and characterization of
starting materials and products (PDF)
AUTHOR INFORMATION
Corresponding Author
■
ORCID
Notes
(19) (a) Auzias, M.; Neuburger, M.; Wegner, H. Synlett 2010, 2010,
2443−2448. (b) Wirtanen, T.; Makela, M. K.; Sarfraz, J.; Ihalainen, P.;
̈
̈
Hietala, S.; Melchionna, M.; Helaja, J. Adv. Synth. Catal. 2015, 357,
3718−3726. (c) Wirtanen, T.; Muuronen, M.; Hurmalainen, J.;
Tuononen, H. M.; Nieger, M.; Helaja, J. Org. Chem. Front. 2016, 3,
1738−1745.
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
(20) (a) Delogu, G. L.; Matos, M. J.; Fanti, M.; Era, B.; Medda, R.;
Pieroni, E.; Fais, A.; Kumar, A.; Pintus, F. Bioorg. Med. Chem. Lett.
2016, 26, 2308−2313. (b) Pu, W.; Yuan, Y.; Lu, D.; Wang, X.; Liu, H.;
Wang, C.; Wang, F.; Zhang, G. Bioorg. Med. Chem. Lett. 2016, 26,
5497−5500.
A.P.A. acknowledges the support of DFG (Heisenberg
scholarship AN 1064/4-1) and the Boehringer Ingelheim
Foundation (Plus 3). L.B. is supported by the Verband der
Chemischen Industrie e.V. We thank Dr. S. Sievers and the
Compound Management and Screening Center (COMAS,
Dortmund) for biological testing.
(21) Tanaka, M.; Muro, E.; Ando, H.; Xu, Q.; Fujiwara, M.; Souma,
Y.; Yamaguchi, Y. J. Org. Chem. 2000, 65, 2972−2978.
(22) (a) Lian, G.; Yu, B. Chem. Biodiversity 2010, 7, 2660−2691.
(b) Wezeman, T.; Masters, K.-S.; Brase, S. Angew. Chem., Int. Ed. 2014,
̈
REFERENCES
■
53, 4524−4526.
(1) (a) Yeung, C. S.; Dong, V. M. Chem. Rev. 2011, 111, 1215−1292.
(b) Liu, C.; Yuan, J.; Gao, M.; Tang, S.; Li, W.; Shi, R.; Lei, A. Chem.
Rev. 2015, 115, 12138−12204.
(23) Basset-Seguin, N.; Sharpe, H. J.; de Sauvage, F. J. Mol. Cancer
Ther. 2015, 14, 633−641.
(2) (a) Bruckl, T.; Baxter, R. D.; Ishihara, Y.; Baran, P. S. Acc. Chem.
̈
Res. 2012, 45, 826−839. (b) Yang, L.; Huang, H. Chem. Rev. 2015,
115, 3468−3517.
(3) (a) Zhang, F.; Spring, D. R. Chem. Soc. Rev. 2014, 43, 6906−
6919. (b) Parasram, M.; Gevorgyan, V. Acc. Chem. Res. 2017, 50,
2038−2053.
(4) (a) Li, B.; Dixneuf, P. H. Chem. Soc. Rev. 2013, 42, 5744−5767.
(b) Sun, C.-L.; Shi, Z.-J. Chem. Rev. 2014, 114, 9219−9280.
(c) Hartwig, J. F.; Larsen, M. A. ACS Cent. Sci. 2016, 2, 281−292.
(5) Cernak, T.; Dykstra, K. D.; Tyagarajan, S.; Vachal, P.; Krska, S.
W. Chem. Soc. Rev. 2016, 45, 546−576.
(6) Itahara, T. J. Chem. Soc., Chem. Commun. 1980, 49b−50.
(7) (a) Masui, K.; Ikegami, H.; Mori, A. J. Am. Chem. Soc. 2004, 126,
5074−5075. (b) Kobayashi, K.; Sugie, A.; Takahashi, M.; Masui, K.;
Mori, A. Org. Lett. 2005, 7, 5083−5085. (c) Takahashi, M.; Masui, K.;
D
Org. Lett. XXXX, XXX, XXX−XXX